Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001171843-17-006756
Filing Date
2017-11-08
Accepted
2017-11-08 16:12:04
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 fs3_110817.htm S-3 170298
2 EXHIBIT 5.1 exh_51.htm EX-5.1 33743
3 EXHIBIT 23.1 exh_231.htm EX-23.1 1965
4 GRAPHIC logo.jpg GRAPHIC 2966
5 GRAPHIC dunn.jpg GRAPHIC 5526
6 GRAPHIC dunnlogo.jpg GRAPHIC 2408
  Complete submission text file 0001171843-17-006756.txt   222419
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221421 | Film No.: 171186730
SIC: 2836 Biological Products, (No Diagnostic Substances)